T7E1 cleavage assay and Sanger sequencing of the PCR amplicons

RG Rihong Guo
YW Yongjie Wan
DX Dan Xu
LC Libin Cui
MD Mingtian Deng
GZ Guomin Zhang
RJ Ruoxin Jia
WZ Wenjun Zhou
ZW Zhen Wang
KD Kaiping Deng
MH Mingrui Huang
FW Feng Wang
YZ Yanli Zhang
request Request a Protocol
ask Ask a question
Favorite

Ear genomic DNA was extracted using a DNA extraction kit (Tiangen, DP348), and genomic DNA was extracted from rabbit embryos and amplified using the REPL1-g Single Cell Kit (Qiagen, 150343) following the manufacturer’s protocol. The genomic regions surrounding each CRISPR target site were amplified using PCR using primers listed in Table S4, then purified using QiaQuick Spin Column (Qiagen, 28704) following manufacturer’s protocol. A total of 200 ng of the purified PCR product was mixed with NEB Buffer 2, and subjected to the reannealing process to enable heteroduplex formation: 95 °C for 10 min, 95 °C to 85 °C ramping at −2 °C/s, 85 °C to 25 °C at −0.25 °C /s, and 25 °C hold for 1 min. After reannealing, products were treated with 0.5 μl T7E1 (NEB, M0302L) for 30 min, and resolved on 2% agarose gel. The PCR products with mutations detected by T7E1 cleavage assay or Sanger sequencing were then sub-cloned into pMD-19T vector (Takara, D103A). For each sample, 8 to 25 random colonies were used for sequencing.

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A